GlassScriptPhysician profile
Alexander B Knudsen
NPI 1831169416
$5,686.05
in general payments reported to CMS, 2019-2025
48 companies · $802 in 2025
The $802 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $581 · 2020: $484 · 2021: $1,243 · 2022: $970 · 2023: $700 · 2024: $906 · 2025: $802.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,408.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $682.99 | 2021-2025 | |
| Novo Nordisk INC | $641.73 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $420.48 | 2019-2025 | Veozah |
| Lilly USA, LLC | $382.55 | 2020-2025 | Mounjaro, Zepbound, Jardiance |
| Glaxosmithkline, LLC. | $357.84 | 2019-2024 | Trelegy Ellipta, Shingrix |
| Pfizer INC. | $346.28 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $279.98 | 2019-2025 | Airsupra |
| Exact Sciences Corporation | $222.66 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $208.17 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Amarin Pharma, INC. | $182.42 | 2019-2021 | |
| Abbott Laboratories | $174.53 | 2019-2025 | Freestyle Libre 2, Freestyle Libre 3 |
| Biohaven Pharmaceutical Holding Company LTD. | $146.43 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $137.20 | 2020-2025 | Xifaxan, Trulance |
| Grifols USA, LLC | $114.07 | 2019-2021 | |
| Abiomed | $107.35 | 2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $93.96 | 2021 | |
| Amgen INC. | $87.25 | 2021-2024 | Repatha, Otezla, Evenity |
| Novartis Pharmaceuticals Corporation | $81.09 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $75.46 | 2022 | |
| Jazz Pharmaceuticals INC. | $68.09 | 2021-2022 | |
| Seqirus USA INC | $62.87 | 2025 | Flucelvax, Fluad |
| Janssen Pharmaceuticals, INC | $61.51 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.51 | 2019-2024 | Jardiance |
| Biofire Diagnostics, LLC | $58.67 | 2021 | |
| Inogen, INC. | $52.24 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Allergan, INC. | $46.50 | 2020 | |
| Intuitive Surgical, INC. | $38.57 | 2022 | |
| Inspire Medical Systems, INC. | $38.55 | 2024-2025 | Inspire |
| Boston Scientific Corporation | $33.92 | 2025 | Watchman Flx |
| Vertex Pharmaceuticals Incorporated | $33.35 | 2025 | |
| Arbor Pharmaceuticals, INC. | $30.17 | 2019-2020 | |
| Corcept Therapeutics | $29.58 | 2025 | Korlym |
| Mayne Pharma Commercial LLC | $29.41 | 2022 | |
| Shield Therapeutics INC | $28.38 | 2023 | Accrufer |
| Ibsa Pharma INC. | $27.12 | 2020-2021 | |
| Vbi Vaccine (Delaware) INC. | $26.28 | 2023 | Prehevbrio |
| Ultragenyx Pharmaceutical INC. | $23.52 | 2021 | |
| Silk Road Medical, INC. | $21.52 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Mylan Specialty L.P. | $20.59 | 2024 | Yupelri |
| Dexcom, INC. | $20.40 | 2024 | Dexcom G6 Transmitter |
| Medtronic, INC. | $19.70 | 2023 | Interstim |
| Gilead Sciences, INC. | $18.29 | 2023 | |
| Sanofi Pasteur INC. | $17.07 | 2023 | |
| Daiichi Sankyo INC. | $16.86 | 2021 | |
| Paratek Pharmaceuticals, INC. | $16.71 | 2020 | |
| Indivior INC. | $16.41 | 2025 | Sublocade |
| Takeda Pharmaceuticals U.S.A., INC. | $14.96 | 2021 | |
| Molnlycke Health Care US, LLC | $12.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Knudsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.